LEBANON, Ind. – Eli Lilly and Company will invest an additional $4.5 billion in Boone County to create a new center for advanced manufacturing and drug development. The Lilly Medicine Foundry ...

Earnings Report 1.401 USD Q3 2024 Earnings Release 10/30/2024 Earnings Report 5.419 USD Q4 2024 Earnings Release 01/30/2025 Earnings Report 5.365 USD Q1 2025 Earnings Release 04/24/2025 Earnings ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their medical records for safety reasons, a move that comes as it builds a case ...

Eli Lilly has seen massive returns this year and is one of the most expensive healthcare stocks in the world. Its new products have strong growth prospects, but their potential may still be ...

Eli Lilly (NYSE:LLY) is reportedly looking to study its popular weight-loss drug Zepbound in people who aren't considered overweight but are still at risk for developing conditions such as diabetes.

Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2024 financial results on Oct. 30, 2024. Lilly will also conduct a conference call that day with the investment community and ...

Naturally, there are some big choices to be made during Frostpunk 2's campaign, and a short-lived character named Lily May becomes the personification of those choices and how they've affected ...

Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey.

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, freeing the company from competing with compounding pharmacies that have ...

Eli Lilly's long-term growth prospects have been secured by the improved supply in H2'24 and the incoming capacity additions from H1'25 onwards. This is on top of the introduction of its D2C ...

Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of the impact of its blockbuster drugs for diabetes and obesity on the use ...

(This story was updated to add new information.)Eli Lilly and Co. is investing an additional $4.5 billion into the LEAP Research and Innovation District in Lebanon, bringing the drug company's ...